QQQ   272.50 (+0.01%)
AAPL   458.10 (-0.42%)
MSFT   208.73 (+0.01%)
FB   260.59 (-0.27%)
GOOGL   1,511.78 (-0.32%)
AMZN   3,147.00 (-0.44%)
NVDA   461.27 (+0.78%)
CGC   17.27 (-0.29%)
BABA   252.77 (-0.37%)
TSLA   1,641.90 (+1.29%)
GE   6.65 (+0.76%)
MU   46.02 (-0.26%)
AMD   81.07 (-0.94%)
T   30.02 (+0.37%)
F   7.08 (+0.71%)
ACB   10.76 (+5.70%)
GILD   68.61 (+0.63%)
NFLX   482.02 (+0.14%)
DIS   130.35 (-0.47%)
BAC   26.54 (+0.72%)
BA   177.79 (+1.75%)
QQQ   272.50 (+0.01%)
AAPL   458.10 (-0.42%)
MSFT   208.73 (+0.01%)
FB   260.59 (-0.27%)
GOOGL   1,511.78 (-0.32%)
AMZN   3,147.00 (-0.44%)
NVDA   461.27 (+0.78%)
CGC   17.27 (-0.29%)
BABA   252.77 (-0.37%)
TSLA   1,641.90 (+1.29%)
GE   6.65 (+0.76%)
MU   46.02 (-0.26%)
AMD   81.07 (-0.94%)
T   30.02 (+0.37%)
F   7.08 (+0.71%)
ACB   10.76 (+5.70%)
GILD   68.61 (+0.63%)
NFLX   482.02 (+0.14%)
DIS   130.35 (-0.47%)
BAC   26.54 (+0.72%)
BA   177.79 (+1.75%)
QQQ   272.50 (+0.01%)
AAPL   458.10 (-0.42%)
MSFT   208.73 (+0.01%)
FB   260.59 (-0.27%)
GOOGL   1,511.78 (-0.32%)
AMZN   3,147.00 (-0.44%)
NVDA   461.27 (+0.78%)
CGC   17.27 (-0.29%)
BABA   252.77 (-0.37%)
TSLA   1,641.90 (+1.29%)
GE   6.65 (+0.76%)
MU   46.02 (-0.26%)
AMD   81.07 (-0.94%)
T   30.02 (+0.37%)
F   7.08 (+0.71%)
ACB   10.76 (+5.70%)
GILD   68.61 (+0.63%)
NFLX   482.02 (+0.14%)
DIS   130.35 (-0.47%)
BAC   26.54 (+0.72%)
BA   177.79 (+1.75%)
QQQ   272.50 (+0.01%)
AAPL   458.10 (-0.42%)
MSFT   208.73 (+0.01%)
FB   260.59 (-0.27%)
GOOGL   1,511.78 (-0.32%)
AMZN   3,147.00 (-0.44%)
NVDA   461.27 (+0.78%)
CGC   17.27 (-0.29%)
BABA   252.77 (-0.37%)
TSLA   1,641.90 (+1.29%)
GE   6.65 (+0.76%)
MU   46.02 (-0.26%)
AMD   81.07 (-0.94%)
T   30.02 (+0.37%)
F   7.08 (+0.71%)
ACB   10.76 (+5.70%)
GILD   68.61 (+0.63%)
NFLX   482.02 (+0.14%)
DIS   130.35 (-0.47%)
BAC   26.54 (+0.72%)
BA   177.79 (+1.75%)
Log in

NASDAQ:SBBPStrongbridge Biopharma Price Target & Analyst Ratings

$3.77
-0.03 (-0.79 %)
(As of 08/14/2020 01:18 PM ET)
Add
Compare
Today's Range
$3.66
Now: $3.77
$3.97
50-Day Range
$3.31
MA: $3.73
$4.24
52-Week Range
$1.43
Now: $3.77
$4.63
Volume17,081 shs
Average Volume391,589 shs
Market Capitalization$204.92 million
P/E RatioN/A
Dividend YieldN/A
Beta1.52

Analyst Ratings

Strongbridge Biopharma (NASDAQ:SBBP) Price Target and Consensus Rating

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
5 Wall Street analysts have issued ratings and price targets for Strongbridge Biopharma in the last 12 months. Their average twelve-month price target is $9.13, suggesting that the stock has a possible upside of 142.04%. The high price target for SBBP is $18.00 and the low price target for SBBP is $5.00. There are currently 5 buy ratings for the stock, resulting in a consensus rating of "Buy."
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: BuyBuyBuyBuy
Consensus Rating Score: 3.003.003.003.00
Ratings Breakdown: 0 Sell Rating(s)
0 Hold Rating(s)
5 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
5 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
5 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
5 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: $9.13$9.88$9.88$13.25
Price Target Upside: 142.04% upside242.88% upside242.88% upside733.33% upside

Strongbridge Biopharma (NASDAQ:SBBP) Consensus Price Target History

Average Share Price and Price Target by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.

Strongbridge Biopharma (NASDAQ:SBBP) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
8/11/2020Jefferies Financial GroupReiterated RatingBuy$5.00Medium
8/5/2020HC WainwrightReiterated RatingBuy$18.00High
5/6/2020OppenheimerReiterated RatingBuy$6.00Medium
3/3/2020Craig HallumInitiated CoverageBuy$7.50Low
9/24/2019Evercore ISIInitiated CoverageOutperformHigh
2/26/2019Cantor FitzgeraldSet Price TargetBuy$12.00High
12/18/2018LaidlawInitiated CoverageBuy ➝ Buy$11.00Low
8/9/2018JMP SecuritiesBoost Price TargetMarket Outperform ➝ Market Outperform$10.00 ➝ $16.00High
8/8/2018Janney Montgomery ScottBoost Price TargetFair Value ➝ Buy$16.00Medium
(Data available from 8/14/2018 forward)
This page was last updated on 8/14/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.